Advertisement


Tim A. Ahles, PhD, on Neurocognitive Late Effects

2016 Cancer Survivorship Symposium

Advertisement

Tim A. Ahles, PhD, of Memorial Sloan Kettering Cancer Center, discusses “chemobrain” and what can be done to help patients cope with this symptom.



Related Videos

Survivorship

Kerri M. Winters-Stone, PhD, on Peripheral Neuropathy: High Prevalence Among Female Survivors

Kerri M. Winters-Stone, PhD, of Oregon Health and Science University, discusses the results of her study, which showed that, years after treatment, nearly half of women cancer survivors still have symptoms of chemotherapy-induced peripheral neuropathy. The findings may inform rehabilitative programs to prevent falls and injuries (Abstract 130).

Survivorship

Tara O. Henderson, MD, MPH, on Cancer Survivors With Complex Medical Needs

Tara O. Henderson, MD, MPH, of the University of Chicago, summarizes a session on the multidisciplinary approaches to survivors with medical needs beyond cancer treatment.

Survivorship

Lewis E. Foxhall, MD, on Communication and Coordination of Survivorship Care

Lewis E. Foxhall, MD, of The University of Texas MD Anderson Cancer Center, summarizes this session in which presenters covered a range of issues, including the medical home, tools to facilitate communication with cancer survivors, EMRs, reimbursement, and coordinating care with primary care providers (Abstract 76 was presented in this session).

Survivorship
Breast Cancer

Jennifer A. Ligibel, MD, on Breast Cancer Survivorship in Young Women

Jennifer A. Ligibel, MD, of the Dana-Farber Cancer Institute, discusses the physical activity behaviors and weight changes in a study cohort of young women with breast cancer (Abstract 166).

Survivorship

Patricia A. Ganz, MD, on Looking Beyond the Scans: What to Look For and How

Patricia A. Ganz, MD, of the University of California at Los Angeles, discusses the limited sensitivity and specificity of surveillance testing for cancer recurrence and finding a better way to reassure patients about their continuing care.

Advertisement

Advertisement



Advertisement